Kymera Therapeutics Inc (KYMR) — Long-term Investment Intensity
Kymera Therapeutics Inc (KYMR) has a Long-term Investment Intensity of 42.9% as of September 2025. Long-term investments of $473.06 Million represent 42.9% of total assets of $1.10 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See shareholders equity of Kymera Therapeutics Inc for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Kymera Therapeutics Inc Long-term Investment Intensity (2020–2024)
This chart shows how Kymera Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the intensity stands at 42.9%, reflecting long-term investments of $473.06 Million against total assets of $1.10 Billion USD. Also explore KYMR total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Kymera Therapeutics Inc (2020–2024)
The table below presents the year-by-year Long-term Investment Intensity for Kymera Therapeutics Inc from 2020 to 2024, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Kymera Therapeutics Inc (KYMR) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 37.0% | $362.16 Million | $978.03 Million | ▲ +26.4 pp |
| 2023 | 10.7% | $61.43 Million | $575.76 Million | ▼ -14.6 pp |
| 2022 | 25.3% | $152.33 Million | $603.13 Million | ▲ +4.6 pp |
| 2021 | 20.7% | $125.19 Million | $605.90 Million | ▼ -12.7 pp |
| 2020 | 33.4% | $162.53 Million | $487.18 Million | — |